Concepedia

Lisa Dinter

LD

Statistics

Publications

2

Citations

25

H-Index

2

Active since

2022

Affiliations

National Center for Tumor Diseases(Current)

German Cancer Research Center

Helmholtz-Zentrum Dresden-Rossendorf

Heidelberg University

Technische Universität Dresden

Lisa Dinter is an author at National Center for Tumor Diseases specializing in tumor biology, cancer therapeutics, and oncology.

Top concepts

Publications per year

2022–2023

2

Publications

2

Head-to-Head Comparison of BRAF/MEK Inhibitor Combinations Proposes Superiority of Encorafenib Plus Trametinib in Melanoma

Alexander Schulz, Jennifer Raetz, Paula C. Karitzky et al. · Cancers · 2022 · 13 citations · Full text

, , +15

<scp>BRAF</scp> and <scp>MEK</scp> inhibitor combinations induce potent molecular and immunological effects in <scp>NRAS</scp>‐mutant melanoma cells: Insights into mode of action and resistance mechanisms

Lisa Dinter, Paula C. Karitzky, Alexander Schulz et al. · International Journal of Cancer · 2023 · 12 citations · Full text

1–2 of 2